Orserdu

(elacestrant)
Orserdu 86 MG Oral TabletOrserdu 345 MG Oral Tablet
NO BLACK BOX WARNING

Dosage & administration

biomarker testing

Orserdu clinical details

Genetic testing requirements were obtained from the NCCN guidelines for each cancer type.

drug label

Orserdu prescribing information

prior authorization

Orserdu prior authorization resources

PDF
Complete Letter of Medical Necessity

PDF
Coverage Authorization Appeals
Learn More

Benefits investigation

PDF
Orserdu Enrollment Form
Learn More

pharmacy

Orserdu preferred pharmacy

OTHER
Pharmacy List

financial assistance

Orserdu financial assistance options

Co-pay savings program

commercial only
Enroll in Patient Savings Program
Learn More

Bridge program

commercial only

PDF
Orserdu Enrollment Form

PDF
Orserdu Rapid Start - Bridge Program
Learn More

Foundation programs

under insured
no insurance
goverment insurance
65+

PDF
Orserdu Enrollment Form
Learn More

patient education

Orserdu patient education

Getting started on Orserdu

To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link

Patient toolkit

BRAND PAGE
About Orserdu
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

OTHER
View How to Take Orserdu
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

BRAND PAGE
Side Effects
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

OTHER
Patient Resources
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDF
Patient Brochure
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Learn More

Other resources

Learn More

people also ask

Orserdu FAQs

How is the dosage of Orserdu?Orserdu is available in 2 dosages, including 345 mg Tab and 86 mg Tab
What does Orserdu treat?Orserdu treats Breast Neoplasms
How Is Orserdu Administered?Orserdu is administered as a Oral Pill
FAQ Data Source